ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Central Nervous System (CNS) Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19Y8825
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Central Nervous System CNS Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Central Nervous System (CNS) Drug Market Research Report 2025

Code: QYRE-Auto-19Y8825
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Pfizer Inc
Novartis
GSK
Eli Lilly
TEVA
Otsuka Pharmaceutical Co Ltd
Biogen
Boehringer Ingelheim
Roche
UCB
Tekeda
Shanghai Fosun
Jiangsu Nhwa Pharmaceutical Co. Ltd.

Central Nervous System (CNS) Drug Market Size

The global market for Central Nervous System (CNS) Drug was valued at US$ 127230 million in the year 2024 and is projected to reach a revised size of US$ 202970 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Central Nervous System (CNS) Drug Market

Central Nervous System (CNS) Drug Market

Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the ability to function. The condition may be an inherited metabolic disorder; the result of damage from an infection, a degenerative condition, stroke, a brain tumor or other problem; or arise from unknown or multiple factors. Movement disorders such as Parkinson’s disease, dystonia, and essential tremor are central nervous system conditions. What they have in common is the loss of sufficient, intact nervous system circuits that orchestrate functions as varied as memory formation (in Alzheimer’s) or voluntary motion (in movement disorders).
The presence of strong pipeline products is expected to drive the central nervous system therapeutics market over the forecast period. Major pharmaceutical companies are focusing on new treatments to prevent or improve symptoms of neurological diseases.
This report aims to provide a comprehensive presentation of the global market for Central Nervous System (CNS) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System (CNS) Drug.
The Central Nervous System (CNS) Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Central Nervous System (CNS) Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Central Nervous System (CNS) Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Central Nervous System (CNS) Drug Market Report

Report Metric Details
Report Name Central Nervous System (CNS) Drug Market
Accounted market size in year US$ 127230 million
Forecasted market size in 2031 US$ 202970 million
CAGR 7.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Pfizer Inc, Novartis AG, GSK, Eli Lilly, Teva, Otsuka Pharmaceutical Co., Ltd, Biogen Inc, Boehringer Ingelheim, Roche, UCB, Tekeda, Shanghai Fosun, Jiangsu Nhwa Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Central Nervous System (CNS) Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Central Nervous System (CNS) Drug Market growing?

Ans: The Central Nervous System (CNS) Drug Market witnessing a CAGR of 7.0% during the forecast period 2025-2031.

What is the Central Nervous System (CNS) Drug Market size in 2031?

Ans: The Central Nervous System (CNS) Drug Market size in 2031 will be US$ 202970 million.

Who are the main players in the Central Nervous System (CNS) Drug Market report?

Ans: The main players in the Central Nervous System (CNS) Drug Market are Johnson & Johnson, Pfizer Inc, Novartis AG, GSK, Eli Lilly, Teva, Otsuka Pharmaceutical Co., Ltd, Biogen Inc, Boehringer Ingelheim, Roche, UCB, Tekeda, Shanghai Fosun, Jiangsu Nhwa Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Central Nervous System (CNS) Drug Market report?

Ans: The Applications covered in the Central Nervous System (CNS) Drug Market report are MS Therapeutics, Antipsychotic Drugs, Depression Drugs, Epilepsy Drugs, Others

What are the Type segmentation covered in the Central Nervous System (CNS) Drug Market report?

Ans: The Types covered in the Central Nervous System (CNS) Drug Market report are Prescription Drugs, OTC

Recommended Reports

Central Nervous System

Neurological Disorders

Mental Health Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Central Nervous System (CNS) Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prescription Drugs
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Central Nervous System (CNS) Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 MS Therapeutics
1.3.3 Antipsychotic Drugs
1.3.4 Depression Drugs
1.3.5 Epilepsy Drugs
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Drug Market Perspective (2020-2031)
2.2 Global Central Nervous System (CNS) Drug Growth Trends by Region
2.2.1 Global Central Nervous System (CNS) Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Central Nervous System (CNS) Drug Historic Market Size by Region (2020-2025)
2.2.3 Central Nervous System (CNS) Drug Forecasted Market Size by Region (2026-2031)
2.3 Central Nervous System (CNS) Drug Market Dynamics
2.3.1 Central Nervous System (CNS) Drug Industry Trends
2.3.2 Central Nervous System (CNS) Drug Market Drivers
2.3.3 Central Nervous System (CNS) Drug Market Challenges
2.3.4 Central Nervous System (CNS) Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Drug Players by Revenue
3.1.1 Global Top Central Nervous System (CNS) Drug Players by Revenue (2020-2025)
3.1.2 Global Central Nervous System (CNS) Drug Revenue Market Share by Players (2020-2025)
3.2 Global Central Nervous System (CNS) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Central Nervous System (CNS) Drug Revenue
3.4 Global Central Nervous System (CNS) Drug Market Concentration Ratio
3.4.1 Global Central Nervous System (CNS) Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Drug Revenue in 2024
3.5 Global Key Players of Central Nervous System (CNS) Drug Head office and Area Served
3.6 Global Key Players of Central Nervous System (CNS) Drug, Product and Application
3.7 Global Key Players of Central Nervous System (CNS) Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Central Nervous System (CNS) Drug Breakdown Data by Type
4.1 Global Central Nervous System (CNS) Drug Historic Market Size by Type (2020-2025)
4.2 Global Central Nervous System (CNS) Drug Forecasted Market Size by Type (2026-2031)
5 Central Nervous System (CNS) Drug Breakdown Data by Application
5.1 Global Central Nervous System (CNS) Drug Historic Market Size by Application (2020-2025)
5.2 Global Central Nervous System (CNS) Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Central Nervous System (CNS) Drug Market Size (2020-2031)
6.2 North America Central Nervous System (CNS) Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Central Nervous System (CNS) Drug Market Size by Country (2020-2025)
6.4 North America Central Nervous System (CNS) Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Central Nervous System (CNS) Drug Market Size (2020-2031)
7.2 Europe Central Nervous System (CNS) Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Central Nervous System (CNS) Drug Market Size by Country (2020-2025)
7.4 Europe Central Nervous System (CNS) Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Central Nervous System (CNS) Drug Market Size (2020-2031)
8.2 Asia-Pacific Central Nervous System (CNS) Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Central Nervous System (CNS) Drug Market Size (2020-2031)
9.2 Latin America Central Nervous System (CNS) Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Central Nervous System (CNS) Drug Market Size by Country (2020-2025)
9.4 Latin America Central Nervous System (CNS) Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Central Nervous System (CNS) Drug Market Size (2020-2031)
10.2 Middle East & Africa Central Nervous System (CNS) Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Introduction
11.1.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Pfizer Inc
11.2.1 Pfizer Inc Company Details
11.2.2 Pfizer Inc Business Overview
11.2.3 Pfizer Inc Central Nervous System (CNS) Drug Introduction
11.2.4 Pfizer Inc Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.2.5 Pfizer Inc Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Central Nervous System (CNS) Drug Introduction
11.3.4 Novartis AG Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.3.5 Novartis AG Recent Development
11.4 GSK
11.4.1 GSK Company Details
11.4.2 GSK Business Overview
11.4.3 GSK Central Nervous System (CNS) Drug Introduction
11.4.4 GSK Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.4.5 GSK Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Central Nervous System (CNS) Drug Introduction
11.5.4 Eli Lilly Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.5.5 Eli Lilly Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Central Nervous System (CNS) Drug Introduction
11.6.4 Teva Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.6.5 Teva Recent Development
11.7 Otsuka Pharmaceutical Co., Ltd
11.7.1 Otsuka Pharmaceutical Co., Ltd Company Details
11.7.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Introduction
11.7.4 Otsuka Pharmaceutical Co., Ltd Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.7.5 Otsuka Pharmaceutical Co., Ltd Recent Development
11.8 Biogen Inc
11.8.1 Biogen Inc Company Details
11.8.2 Biogen Inc Business Overview
11.8.3 Biogen Inc Central Nervous System (CNS) Drug Introduction
11.8.4 Biogen Inc Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.8.5 Biogen Inc Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Introduction
11.9.4 Boehringer Ingelheim Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Central Nervous System (CNS) Drug Introduction
11.10.4 Roche Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.10.5 Roche Recent Development
11.11 UCB
11.11.1 UCB Company Details
11.11.2 UCB Business Overview
11.11.3 UCB Central Nervous System (CNS) Drug Introduction
11.11.4 UCB Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.11.5 UCB Recent Development
11.12 Tekeda
11.12.1 Tekeda Company Details
11.12.2 Tekeda Business Overview
11.12.3 Tekeda Central Nervous System (CNS) Drug Introduction
11.12.4 Tekeda Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.12.5 Tekeda Recent Development
11.13 Shanghai Fosun
11.13.1 Shanghai Fosun Company Details
11.13.2 Shanghai Fosun Business Overview
11.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Introduction
11.13.4 Shanghai Fosun Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.13.5 Shanghai Fosun Recent Development
11.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
11.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Details
11.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview
11.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Introduction
11.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Revenue in Central Nervous System (CNS) Drug Business (2020-2025)
11.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Pfizer Inc
Novartis
GSK
Eli Lilly
TEVA
Otsuka Pharmaceutical Co Ltd
Biogen
Boehringer Ingelheim
Roche
UCB
Tekeda
Shanghai Fosun
Jiangsu Nhwa Pharmaceutical Co. Ltd.
List of Tables
 Table 1. Global Central Nervous System (CNS) Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Prescription Drugs
 Table 3. Key Players of OTC
 Table 4. Global Central Nervous System (CNS) Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Central Nervous System (CNS) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Central Nervous System (CNS) Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Central Nervous System (CNS) Drug Market Share by Region (2020-2025)
 Table 8. Global Central Nervous System (CNS) Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Central Nervous System (CNS) Drug Market Share by Region (2026-2031)
 Table 10. Central Nervous System (CNS) Drug Market Trends
 Table 11. Central Nervous System (CNS) Drug Market Drivers
 Table 12. Central Nervous System (CNS) Drug Market Challenges
 Table 13. Central Nervous System (CNS) Drug Market Restraints
 Table 14. Global Central Nervous System (CNS) Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Central Nervous System (CNS) Drug Market Share by Players (2020-2025)
 Table 16. Global Top Central Nervous System (CNS) Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Drug as of 2024)
 Table 17. Ranking of Global Top Central Nervous System (CNS) Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Central Nervous System (CNS) Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Central Nervous System (CNS) Drug, Headquarters and Area Served
 Table 20. Global Key Players of Central Nervous System (CNS) Drug, Product and Application
 Table 21. Global Key Players of Central Nervous System (CNS) Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Central Nervous System (CNS) Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global Central Nervous System (CNS) Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Central Nervous System (CNS) Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global Central Nervous System (CNS) Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global Central Nervous System (CNS) Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America Central Nervous System (CNS) Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Central Nervous System (CNS) Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Central Nervous System (CNS) Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Central Nervous System (CNS) Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Central Nervous System (CNS) Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Central Nervous System (CNS) Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Central Nervous System (CNS) Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Central Nervous System (CNS) Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Central Nervous System (CNS) Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Central Nervous System (CNS) Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Central Nervous System (CNS) Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Johnson & Johnson Company Details
 Table 47. Johnson & Johnson Business Overview
 Table 48. Johnson & Johnson Central Nervous System (CNS) Drug Product
 Table 49. Johnson & Johnson Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 50. Johnson & Johnson Recent Development
 Table 51. Pfizer Inc Company Details
 Table 52. Pfizer Inc Business Overview
 Table 53. Pfizer Inc Central Nervous System (CNS) Drug Product
 Table 54. Pfizer Inc Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 55. Pfizer Inc Recent Development
 Table 56. Novartis AG Company Details
 Table 57. Novartis AG Business Overview
 Table 58. Novartis AG Central Nervous System (CNS) Drug Product
 Table 59. Novartis AG Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 60. Novartis AG Recent Development
 Table 61. GSK Company Details
 Table 62. GSK Business Overview
 Table 63. GSK Central Nervous System (CNS) Drug Product
 Table 64. GSK Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 65. GSK Recent Development
 Table 66. Eli Lilly Company Details
 Table 67. Eli Lilly Business Overview
 Table 68. Eli Lilly Central Nervous System (CNS) Drug Product
 Table 69. Eli Lilly Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 70. Eli Lilly Recent Development
 Table 71. Teva Company Details
 Table 72. Teva Business Overview
 Table 73. Teva Central Nervous System (CNS) Drug Product
 Table 74. Teva Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 75. Teva Recent Development
 Table 76. Otsuka Pharmaceutical Co., Ltd Company Details
 Table 77. Otsuka Pharmaceutical Co., Ltd Business Overview
 Table 78. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product
 Table 79. Otsuka Pharmaceutical Co., Ltd Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 80. Otsuka Pharmaceutical Co., Ltd Recent Development
 Table 81. Biogen Inc Company Details
 Table 82. Biogen Inc Business Overview
 Table 83. Biogen Inc Central Nervous System (CNS) Drug Product
 Table 84. Biogen Inc Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 85. Biogen Inc Recent Development
 Table 86. Boehringer Ingelheim Company Details
 Table 87. Boehringer Ingelheim Business Overview
 Table 88. Boehringer Ingelheim Central Nervous System (CNS) Drug Product
 Table 89. Boehringer Ingelheim Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 90. Boehringer Ingelheim Recent Development
 Table 91. Roche Company Details
 Table 92. Roche Business Overview
 Table 93. Roche Central Nervous System (CNS) Drug Product
 Table 94. Roche Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 95. Roche Recent Development
 Table 96. UCB Company Details
 Table 97. UCB Business Overview
 Table 98. UCB Central Nervous System (CNS) Drug Product
 Table 99. UCB Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 100. UCB Recent Development
 Table 101. Tekeda Company Details
 Table 102. Tekeda Business Overview
 Table 103. Tekeda Central Nervous System (CNS) Drug Product
 Table 104. Tekeda Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 105. Tekeda Recent Development
 Table 106. Shanghai Fosun Company Details
 Table 107. Shanghai Fosun Business Overview
 Table 108. Shanghai Fosun Central Nervous System (CNS) Drug Product
 Table 109. Shanghai Fosun Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 110. Shanghai Fosun Recent Development
 Table 111. Jiangsu Nhwa Pharmaceutical Co., Ltd. Company Details
 Table 112. Jiangsu Nhwa Pharmaceutical Co., Ltd. Business Overview
 Table 113. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product
 Table 114. Jiangsu Nhwa Pharmaceutical Co., Ltd. Revenue in Central Nervous System (CNS) Drug Business (2020-2025) & (US$ Million)
 Table 115. Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Central Nervous System (CNS) Drug Picture
 Figure 2. Global Central Nervous System (CNS) Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Central Nervous System (CNS) Drug Market Share by Type: 2024 VS 2031
 Figure 4. Prescription Drugs Features
 Figure 5. OTC Features
 Figure 6. Global Central Nervous System (CNS) Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Central Nervous System (CNS) Drug Market Share by Application: 2024 VS 2031
 Figure 8. MS Therapeutics Case Studies
 Figure 9. Antipsychotic Drugs Case Studies
 Figure 10. Depression Drugs Case Studies
 Figure 11. Epilepsy Drugs Case Studies
 Figure 12. Others Case Studies
 Figure 13. Central Nervous System (CNS) Drug Report Years Considered
 Figure 14. Global Central Nervous System (CNS) Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Central Nervous System (CNS) Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Central Nervous System (CNS) Drug Market Share by Region: 2024 VS 2031
 Figure 17. Global Central Nervous System (CNS) Drug Market Share by Players in 2024
 Figure 18. Global Top Central Nervous System (CNS) Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Drug as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Drug Revenue in 2024
 Figure 20. North America Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Central Nervous System (CNS) Drug Market Share by Country (2020-2031)
 Figure 22. United States Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Central Nervous System (CNS) Drug Market Share by Country (2020-2031)
 Figure 26. Germany Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Central Nervous System (CNS) Drug Market Share by Region (2020-2031)
 Figure 34. China Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Central Nervous System (CNS) Drug Market Share by Country (2020-2031)
 Figure 42. Mexico Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Central Nervous System (CNS) Drug Market Share by Country (2020-2031)
 Figure 46. Turkey Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Central Nervous System (CNS) Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Johnson & Johnson Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 50. Pfizer Inc Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 51. Novartis AG Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 52. GSK Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 53. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 54. Teva Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 55. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 56. Biogen Inc Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 57. Boehringer Ingelheim Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 58. Roche Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 59. UCB Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 60. Tekeda Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 61. Shanghai Fosun Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 62. Jiangsu Nhwa Pharmaceutical Co., Ltd. Revenue Growth Rate in Central Nervous System (CNS) Drug Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Drugs for Central Nervous System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Central Nervous System Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Central Nervous System Disorders Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Central Nervous System Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Central Nervous System Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs for Central Nervous System Diseases Market Insights Forecast to 2030
Global Parkinson s Disease Therapeutics Market Research Report 2025
Global Alzheimers and Parkinsons Diseases Market Insights Forecast to 2030
Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030
Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Multiple Sclerosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Parkinson s Disease Treatment Market Insights Forecast to 2030
Global Central Nervous System Biomarkers Market Insights Forecast to 2030
Central Nervous System Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurodegenerative Disease Market Insights Forecast to 2030
Global Nervous System Chemicals Market Research Report 2024
Global Alzheimer s Disease Drug Market Insights Forecast to 2030
Global Demyelinating Diseases Therapeutics Market Research Report 2024
Global Dystonia Drugs Market Research Report 2025
Autoimmune Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13Z8760
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Intracranial Pressure (ICP) Monitoring Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37L4006
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Brain Disease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12P6151
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3X6389
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions